Cervical Cancer Screening Market worth $22 Billion by 2020

The report “Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020”, the cervical cancer screening market is poised to reach $22 billion by 2020 from ~$15 billion in 2014, at an estimated CAGR of 7.0% from 2015 to 2020.

Browse 61 market data tables and 24 figures spread through 200 pages and in-depth TOC on “Cervical Cancer Screening Market"http://www.marketsandmarkets.com/Market-Reports/cervical-cancer-screening-market-10110147.htmlEarly buyers will receive 10% customization on this report.

Factors such as rising prevalence of cervical cancer and favorable government initiatives and funding to increase disease awareness are driving the global market. However, the availability of HPV vaccines, uncertain reimbursement rates, and changes in regulatory guidelines are hindering the growth of this market.

The global market is segmented on the basis of test types, end users, and geographies. Based on test type, the cervical cancer screening market is segmented into pap tests and HPV/co tests.

Ask For The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=10110147

Among both, the HPV/co-test is estimated to grow at a higher CAGR during the forecast period. This growth can largely be attributed to the growing incidences of cervical cancer, higher consistency and effectiveness of HPV tests and co-tests that reduce the annual cost of the treatment and changing regulatory guidelines in favor of HPV tests.

On the basis end users, the global market is classified into hospitals, laboratories, and independent physicians’ offices and clinics. The laboratories segment accounted for the largest share in 2014, while the hospitals segment is estimated to grow at a faster rate due to the increasing volume of patients in hospitals.

On the basis of geography, the global market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2014, North America accounted for the largest share of the global market, followed by Europe. Both these markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region. Growth of the cervical cancer screening market in the Asia-Pacific region will revolve around China, India, Australia, and countries in the Middle East.

Get The Sample Copy Of This Report:

http://www.marketsandmarkets.com/requestsample.asp?id=10110147

The key players in the cervical cancer screening tests and kits market are Hologic (U.S.), Qiagen N.V. (Netherlands), Becton, Dickinson and Company (U.S.), and Hoffman-La Roche (Switzerland).

Browse Related Reports:

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018

http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:Mr. RohanUnit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices